Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Colorectal Neoplasms

  Free Subscription


26.03.2018

1 Am J Surg
2 Ann Oncol
1 Ann Surg Oncol
1 BMC Cancer
2 Br J Cancer
1 Cancer Lett
1 Dis Colon Rectum
1 Gut
3 Int J Colorectal Dis
1 J Clin Oncol
2 Lancet Oncol
3 Oncogene
2 Oncol Rep
1 PLoS One
1 World J Surg


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Surg

  1. PRESTON MA, Mays GP, Bursac Z, Thomas BR, et al
    Insurance coverage mandates: Impact of physician utilization in moderating colorectal cancer screening rates.
    Am J Surg. 2018 Mar 2. pii: S0002-9610(17)31075.
    PubMed     Text format     Abstract available


    Ann Oncol

  2. MALVEZZI M, Carioli G, Bertuccio P, Boffetta P, et al
    European cancer mortality predictions for the year 2018 with focus on colorectal cancer.
    Ann Oncol. 2018 Mar 19. pii: 4935197. doi: 10.1093.
    PubMed     Text format     Abstract available

  3. MONTAGUT C, Tsui DW, Diaz LA Jr.
    Detection of somatic RAS mutations in circulating tumor DNA from metastatic colorectal cancer patients: are we ready for clinical use?
    Ann Oncol. 2018 Mar 14. pii: 4937227. doi: 10.1093.
    PubMed     Text format    


    Ann Surg Oncol

  4. SIMONEAU E, Vauthey JN
    Progression of Colorectal Cancer Liver Metastasis After Chemotherapy: A New Test of Time?
    Ann Surg Oncol. 2018 Mar 19. pii: 10.1245/s10434-018-6439.
    PubMed     Text format    


    BMC Cancer

  5. BUROCK S, Daum S, Keilholz U, Neumann K, et al
    Phase II trial to investigate the safety and efficacy of orally applied niclosamide in patients with metachronous or sychronous metastases of a colorectal cancer progressing after therapy: the NIKOLO trial.
    BMC Cancer. 2018;18:297.
    PubMed     Text format     Abstract available


    Br J Cancer

  6. SHINOZAKI E, Yoshino T, Tsuchihara K
    Reply to `Comment on `Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Ant
    Br J Cancer. 2018 Mar 22. pii: 10.1038/s41416-018-0040.
    PubMed     Text format    

  7. DANKNER M, Rose AAN
    Comment on 'Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Antibodies by
    Br J Cancer. 2018 Mar 22. pii: 10.1038/s41416-018-0012.
    PubMed     Text format    


    Cancer Lett

  8. BASU S, Gavert N, Brabletz T, Ben-Ze'ev A, et al
    The intestinal stem cell regulating gene ASCL2 is required for L1-mediated colon cancer progression.
    Cancer Lett. 2018 Mar 15. pii: S0304-3835(18)30219.
    PubMed     Text format     Abstract available


    Dis Colon Rectum

  9. MAYANAGI S, Kashiwabara K, Honda M, Oba K, et al
    Risk Factors for Peritoneal Recurrence in Stage II to III Colon Cancer.
    Dis Colon Rectum. 2018 Mar 20. doi: 10.1097/DCR.0000000000001002.
    PubMed     Text format     Abstract available


    Gut

  10. DAVENPORT JR, Su T, Zhao Z, Coleman HG, et al
    Modifiable lifestyle factors associated with risk of sessile serrated polyps, conventional adenomas and hyperplastic polyps.
    Gut. 2018;67:456-465.
    PubMed     Text format     Abstract available


    Int J Colorectal Dis

  11. RAMAI D, Etienne D, Reddy M
    Does mistrust still linger? A bioethical perspective on colorectal cancer screening.
    Int J Colorectal Dis. 2018 Mar 19. pii: 10.1007/s00384-018-3029.
    PubMed     Text format    

  12. OH BY, Huh JW, Kim HC, Park YA, et al
    Oncologic outcome of colorectal cancer patients over age 80: a propensity score-matched analysis.
    Int J Colorectal Dis. 2018 Mar 21. pii: 10.1007/s00384-018-3028.
    PubMed     Text format     Abstract available

  13. FENG Y, Dai W, Li Y, Mo S, et al
    The effect of marital status by age on patients with colorectal cancer over the past decades: a SEER-based analysis.
    Int J Colorectal Dis. 2018 Mar 15. pii: 10.1007/s00384-018-3017.
    PubMed     Text format     Abstract available


    J Clin Oncol

  14. SUN R, Horiguchi M, Wei LJ
    Interpreting the Benefit of Trifluridine/Tipiracil in Metastatic Colorectal Cancer With Respect to Progression-Free Survival and Overall Survival.
    J Clin Oncol. 2018 Mar 20:JCO2017775643. doi: 10.1200/JCO.2017.77.5643.
    PubMed     Text format    


    Lancet Oncol

  15. PRICE TJ
    Modified XELIRI (capecitabine plus irinotecan) for metastatic colorectal cancer.
    Lancet Oncol. 2018 Mar 16. pii: S1470-2045(18)30194.
    PubMed     Text format    

  16. XU RH, Muro K, Morita S, Iwasa S, et al
    Modified XELIRI (capecitabine plus irinotecan) versus FOLFIRI (leucovorin, fluorouracil, and irinotecan), both either with or without bevacizumab, as second-line therapy for metastatic colorectal cancer (AXEPT): a multicentre, open-label, randomised,
    Lancet Oncol. 2018 Mar 16. pii: S1470-2045(18)30140.
    PubMed     Text format     Abstract available


    Oncogene

  17. ZHANG Y, Wang S, Kang W, Liu C, et al
    CREPT facilitates colorectal cancer growth through inducing Wnt/beta-catenin pathway by enhancing p300-mediated beta-catenin acetylation.
    Oncogene. 2018 Mar 22. pii: 10.1038/s41388-018-0161.
    PubMed     Text format     Abstract available

  18. CHU PC, Lin PC, Wu HY, Lin KT, et al
    Mutant KRAS promotes liver metastasis of colorectal cancer, in part, by upregulating the MEK-Sp1-DNMT1-miR-137-YB-1-IGF-IR signaling pathway.
    Oncogene. 2018 Mar 21. pii: 10.1038/s41388-018-0222.
    PubMed     Text format     Abstract available

  19. SAPONARO C, Sergio S, Coluccia A, De Luca M, et al
    beta-catenin knockdown promotes NHERF1-mediated survival of colorectal cancer cells: implications for a double-targeted therapy.
    Oncogene. 2018 Mar 19. pii: 10.1038/s41388-018-0170.
    PubMed     Text format     Abstract available


    Oncol Rep

  20. MAO L, Chen Q, Gong K, Xu X, et al
    Berberine decelerates glucose metabolism via suppression of mTORdependent HIF1alpha protein synthesis in colon cancer cells.
    Oncol Rep. 2018;39:2436-2442.
    PubMed     Text format     Abstract available

  21. YU Y, Peng K, Li H, Zhuang R, et al
    SP1 upregulated FoxO3a promotes tumor progression in colorectal cancer.
    Oncol Rep. 2018;39:2235-2242.
    PubMed     Text format     Abstract available


    PLoS One

  22. JIAO X, Liu W, Mahdessian H, Bryant P, et al
    Recurrent, low-frequency coding variants contributing to colorectal cancer in the Swedish population.
    PLoS One. 2018;13:e0193547.
    PubMed     Text format     Abstract available


    World J Surg

  23. LEIJSSEN LGJ, Dinaux AM, Amri R, Kunitake H, et al
    A Transverse Colectomy is as Safe as an Extended Right or Left Colectomy for Mid-Transverse Colon Cancer.
    World J Surg. 2018 Mar 19. pii: 10.1007/s00268-018-4582.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: